Growth funding Nourish Care has recently secured a significant growth investment of $27.1M with involvement from Hg and Hg Mercury Fund partners, signaling strong validation and additional capital for scalability. This implies openness to further strategic partnerships, enterprise deals, and expansion of platform capabilities.

Expanded eMAR roadmap Nourish is actively developing electronic medication administration record (eMAR) capabilities with a planned launch in Q4, supported by a dedicated team. This presents opportunities to upsell to existing clients and to collaborate with health tech suppliers and pharmacies seeking integrated medication workflows.

NHS and integrations Validated by NHS England Assured Solutions listing and a broad integration partner ecosystem, Nourish presents a strong case for expanding with health and social care providers that require reliable interoperability and compliance, including potential co-sell with integration partners.

Market presence scale Serving 400,000 people with 350,000 daily carers across multiple care settings demonstrates broad deployment and credible referenceability, enabling targeted enterprise sales to larger providers and multi-site organizations seeking scalable digital care records.

Strategic leadership Key personnel moves, including a director of data and AI, indicate a data-driven, innovative trajectory. This can be leveraged to position Nourish as a partner for advanced analytics, personalized care workflows, and AI-enabled care planning opportunities.